Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Proposed 510(k) Changes Elicit Some Industry Skepticism

Executive Summary

Two 510(k) pilots from US FDA indicate the agency's desire for faster, easier clearances. But some observers aren’t sure if they’ll lead to real improvements.

You may also be interested in...

Not So Fast: FDA Announces End Of QUIK 510(k) Pilot

The pilot program from the US agency is set to close on 30 May after regulators found the competing eSTAR project offered more advantages.

Ophthalmic Equipment 510(k)s Evaluated In US FDA Pilot

FDA is recruiting companies to participate in a 510(k) pilot program for optical coherence tomography (OCT) devices. This is the third 510(k) pilot program announced in recent months.

FDA Looks To Expand Special 510(k) Program

US FDA released a draft guidance on the special 510(k) program in an effort to expand and improve the pathway.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts